Price:
Rs. 17,500.00
Sample Type: Amniotic fluid , EDTA Blood
Fasting Not Requierd
Frequently Asked Questions (FAQ's):
What does this fetal aneuploidy test include at Metropolis Healthcare?
It includes QF-PCR for rapid detection of trisomies 13, 18, 21, and XY abnormalities, along with Chromosomal Array CGH for detailed chromosomal evaluation at Metropolis Healthcare.
How does Metropolis Healthcare perform QF-PCR karyotyping?
Metropolis Healthcare uses quantitative fluorescence PCR to quickly analyze specific chromosomal markers linked to common aneuploidies.
What is the role of Chromosomal Array CGH in this test?
Array CGH detects chromosomal gains or losses across the genome, allowing Metropolis Healthcare to identify abnormalities beyond standard karyotyping.
Who should consider this fetal aneuploidy test?
Expecting mothers with high-risk screening results, abnormal ultrasound findings, or advanced maternal age may benefit from this Metropolis Healthcare prenatal test.
Is this test invasive?
The analysis is performed on fetal DNA obtained through procedures such as amniocentesis or chorionic villus sampling, guided by a clinician in coordination with Metropolis Healthcare.
How accurate is fetal aneuploidy detection at Metropolis Healthcare?
Combining QF-PCR and Array CGH enhances accuracy, allowing Metropolis Healthcare to provide both rapid results and comprehensive genomic insight.
How long does it take to receive the results?
QF-PCR findings are usually available sooner, while complete results including Array CGH follow within the standard Metropolis Healthcare reporting timeline.
Can this test detect all genetic disorders?
No, it focuses on common aneuploidies and chromosomal imbalances; Metropolis Healthcare may recommend additional genetic tests if clinically needed.